Hikma Pharmaceuticals Share News (HIK)

London midday: Hikma, COLT lead stocks higher despite Greek negativity

UK stocks advanced on Friday as investors shrugged off a disappointing end to the Eurogroup meeting on Greece, and instead sought out bargains following the recent sell-off. The FTSE 100, which dropped to levels not seen since January earlier in the week, was trading up 0.54% at 6,744.20 by midday.

WINNERS & LOSERS: Colt Group Surges On Takeover Offer From Fidelity

TOP NEWS: Eurozone Calls Crisis Summit As Greece Teeters On Brink

LONDON MARKET MID-MORNING: Stocks Higher Led By Hikma And Colt

Hikma shares jump after Citi upgrade to 'buy'

Pharmaceuticals group Hikma was a high riser on the FTSE 100 on Friday after analysts at Citigroup upgraded the stock from 'neutral' to 'buy', recommending investors "keep the faith" despite a recent drop in the shares. The stock has plunged over 25% since Citi's downgrade to 'neutral' in late Febru

BROKER RATINGS SUMMARY: Citi Upgrades Hikma To Buy From Neutral

London open: Stocks shrug off Greek woes, Hikma and COLT surge

UK stocks edged higher on Friday morning despite a bleak outcome to the Eurogroup meeting, as finance minsters failed to come up with proposals to solve the Greek debt crisis. However, given that expectations were low going into Thursday's meeting, disappointment may have already been priced in, ana

BUZZ-Hikma: top of Stoxx on Citi upgrade

** Hikma Pharmaceuticals top of Stoxx 600 as Citi hikes rating to "buy" vs "neutral" on valuation grounds ** Stock, up 5.3 pct, poised for biggest one-day rise since early January & bouncing clear of 7-mth lows ** Broker flags shares down >25% (since late Feb), exceeding consensus EP

LONDON BRIEFING: Fidelity Offer For Colt Distracts From Greece

LONDON MARKET COMMENT: Stock Futures Turn Lower On Greek Standstill

Dividends Calendar - Week Ahead

Dividends Calendar - Week Ahead

Dividends Calendar - Week Ahead

Dividends Calendar - Week Ahead

Dividends Calendar - Week Ahead